See more
What is the forecast for NVAX stock?
Stock Price Forecast The 6 analysts offering 12-month price forecasts for Novavax Inc have a median target of 160.50, with a high estimate of 207.00 and a low estimate of 35.00. The median estimate represents a +192.83% increase from the last price of 54.81.
Is NVAX a buy Zacks?
Novavax, Inc. - Buy. Zacks' proprietary data indicates that Novavax, Inc. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the NVAX shares relative to the market in the next few months.
Does NVAX pay a dividend?
NVAX does not currently pay a dividend.
Why is NVAX stock dropping?
With Novavax (NASDAQ: NVAX) shares down by more than 70% in the past 12 months, investors are probably feeling a bit devastated right now. The shares even crashed on July 13, when its vaccine candidate for COVID-19 got an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA).
Is Nvax a good long term investment?
Fundamental Analysis Of NVAX Stock In 2021, Novavax lost $23.44 per share, widening from a per-share loss of $7.27 in 2020. Analysts expected a loss of $13.70 per share in 2021. This year, analysts expect Novavax to become profitable with per-share earnings of $24.18.
Is NIO a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Does Moderna have a dividend?
MRNA Moderna, Inc. MRNA does not currently pay a dividend.
Is Nvax a good buy now?
Only two recommend Novavax as a strong buy. But there's another piece of data that bolsters the argument that analysts are actually very bullish about Novavax. The consensus Wall Street 12-month price target for Novavax is $158.67. That's nearly 3.4 times the current share price.
Will Nvax go up tomorrow?
Tomorrow's movement Prediction of Novavax, Inc. NVAX as on 20 Jul 2022 appears strongly Bullish. This stock started moving upwards as soon as it opened....Munafa value: 65 as on 20 Wed Jul 2022.Upside target67.66Upside target63.61Upside target61.17Upside target60.46Downside target56.535 more rows
Is Novavax any good?
How efficacious is the vaccine? The efficacy of Novavax (NVX-CoV2373) has been assessed in three Phase 2 and Phase 3 trials. Of the two Phase 3 trials, both found that the efficacy of the vaccine against mild, moderate, and severe disease is 90%.